Through RNA‐seq analysis, we have also shown differential expression of other cancer biomarkers by CHRDL2, such as EGR1, REG4 and TFF1, which have been shown to regulate proliferation, migration and metastasis. This evidence concerns the gene CHRDL2 and cancer.